Harness clinically driven, real-world data intuitively visualized with Cohort Builder
Accelerate your biomarker programs, clinical trials and commercial launches with real-time, longitudinal lab data from NeoNucleus, the only cancer testing database covering the complete spectrum of oncology testing modalities for over 1.9 million patients with the highest level of allowable demographic information.
Build patient cohorts in seconds with Cohort Builder’s intuitive drag and drop interface to identify clinically actionable candidates in real-time. Visualize your designed cohorts through a library of packaged reports and dashboards, empowering you to make critical decisions faster and with confidence.
See Cohort Builder Up Close
In precision oncology, lab data matters.
Finding patients that match your research and commercial interests is hard. Especially when you are targeting patients with rare diseases or specific biomarkers. Current sources of data, such as EMR and claims data, are incomplete and arrive too late to influence therapeutic decisions.
NeoGenomics Cohort Builder is a first-of-its-kind solution that gives you real-time access to lab data that can indicate biomarker results before a treatment decision is made. And because lab data is longitudinal, you have insight into the entire patient journey, enabling you to build accurate patient cohorts in seconds and visualize the data to make meaningful decisions faster.
Our extensive patient database consists of clinical, pathology and lab data spanning the entire patient journey allowing you to build robust cohorts longitudinally.
We act as a collaborative partner to pathologists and oncologists at community practices and hospitals across the U.S.
Our comprehensive testing menu of over 650 tests encompasses all major testing methodologies – Flow Cytometry, FISH, IHC, Cytogenetics, and NGS.
Our robust, multi-modality and heterogenous image bank supports cell classification, expression scoring, spatial analysis and neural network training projects.
GET THE FACT SHEET: LEARN HOW COHORT BUILDER CAN OPTIMIZE YOUR PRECISION ONCOLOGY PROGRAMS
Find your patient population of interest from community hospitals and oncology clinics across the US where nearly 80% of oncology patients are treated and biomarker testing disparities are most prevalent.
READ THE CASE STUDY: EXPLORE THE VALUE OF HAVING NEOGENOMICS COHORT BUILDER AT YOUR FINGERTIPS
From pre-clinical to post-launch surveillance, this paper details real-world use cases for generating insight across the drug development lifecycle with the ultimate goal of accelerating precision medicine.
See Cohort Builder Live
Schedule a demo with a NeoGenomics Data Strategy Consultant to learn how this powerful interface can support and accelerate your biomarker programs, oncology clinical trials and commercial launches.